Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?

• Published in: Frontiers in oncology Vol. 12; p. 927123
• Main Authors: Yan, Jingxin, Li, Ting, Deng, Manjun, Fan, Haining
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 16.06.2022
• Subjects: ablation; interventional radiology; Oncology; prognosis; rupture of hepatocellular carcinoma; transarterial chemoembolization (TACE); transarterial embolization (TAE)
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2022.927123

Rupture of HCC (rHCC) is a life-threatening complication of hepatocellular carcinoma (HCC), and rHCC may lead to a high rate of peritoneal dissemination and affect survival negatively. Treatment for rHCC mainly includes emergency surgery, interventional therapies, and palliative treatment. However, the management of rHCC should be carefully evaluated. For patients with severe bleeding, who are not tolerant to open surgery, quick hemostatic methods such as rupture tissue ablation and TAE/TACE can be performed. We described clinical presentation, prognosis, complication, interventional management, and current evidence of rHCC from the perspective of interventional radiologists. Overall, our review summarized that interventional therapies are necessary for most patients with rHCC to achieve hemostasis, even in some patients with Child–Pugh C. Moreover, TAE/TACE followed by staged hepatectomy is a beneficial treatment for rHCC according to current clinical evidence. TAE/TACE is the first choice for most patients with rHCC, and appropriate interventional treatment may provide staged surgery opportunities for those who are not tolerant to emergency surgery to reach an ideal prognosis.